| 167028 |
NEURO-ONCOLOGY |
P15.01 WOUND HEALING COMPLICATIONS IN BRAIN TUMOR PATIENTS ON BEVACIZUMAB |
2014-09-01 |
10.1093/neuonc/nou174.280 |
Ladha H., Pawar T., Gilbert M. R., Armstrong T. S. |
| 167027 |
BMB REPORTS |
Oleanolic acid regulates NF-κB signaling by suppressing MafK expression in RAW 264.7 cells |
2014-09-01 |
|
황유진, 송재환, 김행란, 황경아 |
| 167026 |
NEURO-ONCOLOGY |
P17.03 POST-OPERATIVE EXCLUSIVE CHEMOTHERAPY WITH PCV FOR ANAPLASTIC OLIGODENDROGLIOMA: A RETROSPECTIVE STUDY OF 35 CONFIRMED CASES |
2014-09-01 |
10.1093/neuonc/nou174.333 |
Augereau P., Rousseau A., Michalak S., Pavageau A., Loussouarn D., Jadaud E., Nader E., Menei P., Soulie P. |
| 167025 |
NEURO-ONCOLOGY |
P02.05 CLINICAL STUDY PHASE II WITH DENDRITIC CELL VACCINATION AND TUMOUR LYSATE AS ADD-ON THERAPY IN HIGH GRADE GLIOMA |
2014-09-01 |
10.1093/neuonc/nou174.121 |
Stragliotto G., Holm S., Adamson L., Giraud G., Henter J. I. |
| 167024 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Transient hypofibrinogenemia due to allopurinol |
2014-09-01 |
10.2147/dddt.s66868 |
Yin Zhi Qiang, Luo Dan, Xu JiaLi, Li YongQiang, Xia JiPing |
| 167023 |
BMB REPORTS |
TM4SF5-mediated protein-protein networks and tumorigenic roles |
2014-09-01 |
|
이정원 |
| 167022 |
ONCOTARGETS AND THERAPY |
Nanotetrac targets integrin αvβ3 on tumor cells to disorder cell defense pathways and block angiogenesis |
2014-09-01 |
10.2147/ott.s67393 |
Davis Paul, Lin Hung-Yun, Thangirala Sudha, Yalcin Murat, Tang Heng-Yuan, Hercbergs Aleck, Leith John, Luidens Mary, Ashur-Fabian Osnat, Incerpi Sandra, Mousa Shaker |
| 167021 |
NEURO-ONCOLOGY |
P16.03 UNIFYING CLINICAL ROUTINE BRAIN TUMOR MR-SPECTROSCOPY AND MR-IMAGE ANALYSIS: NOVEL JMRUI PLUG-INS FOR BRAIN TUMOR ANALYSIS |
2014-09-01 |
10.1093/neuonc/nou174.300 |
Barros N., Jablonski M., Pica A., Starcukova J., Knecht U., Wiest R., Slotboom J. |
| 167020 |
NEURO-ONCOLOGY |
P06.11 CLINICAL OUTCOME OF WORLD HEALTH ORGANIZATION GRADE II AND III MENINGIOMAS |
2014-09-01 |
10.1093/neuonc/nou174.177 |
Moon J., Kim E., Chang J. |
| 167019 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Combination therapy with sivelestat and recombinant human soluble thrombomodulin for ARDS and DIC patients |
2014-09-01 |
10.2147/dddt.s68030 |
Miyoshi Seigo, Ito Ryoji, Katayama Hitoshi, Dote Kentaro, Aibiki Mayuki, Hamada Hironobu, Okura Takafumi, Higaki Jitsuo |
